The use of systemic medications in pediatric dermatoses
Abstract
The objective of this review focused on pharmaceutical products for the treatment of childhood skin diseases is to guide dermatologists in the goal-oriented choice of optimal medicines. We have listed the most common side effects appearing during drug administration.
The article deals with special features of pharmacokinetics and pharmacodynamics of drugs administered to children in the neonatal period. We have listed the most common side effects appearing during drug administration, and measures for preventing them have been suggested.
About the Authors
M. V. KachukBelarus
A. P. Muzychenkа
Belarus
Т. А. Sikorskaya
Belarus
References
1. Ф. А. Зверькова. Болезни кожи детей раннего возраста. Санкт-Петербург. – Сотис. – 1994. – 235 с.
2. К. Н. Суворова, А. А. Антоньев, Н. П. Кузнецова, И. О. Малова. Кожные и венерические болезни у детей. Иркутск, – Изд-во Иркутского унивта. – 1995.
3. Conroy, S. Survey of unlicensed and off label drug use in paediatric wards in European countries / S. Conroy [et al.] // BMJ. - 2000.
4. Cutroneo, P. M., Arcoraci V., Cucinotta G. et al. Adverse drug reactions in childhood. A drug surveillance study in Sicily // Recent. Prog. Med. – 2007.
5. Frossard N., Vita-Durand D. Duration of antihistaminic effect following discontinuation of ebastine. Allergy 2001; 56:553-557.
6. Hong E, Smith S, Fischer G. Pediatric Dermatology. 2011; Vol. 28. Iss. 4. P. 393–396.
7. Lucy AW, Leach AD, Laskarzewski P, Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Ped Dermatol. 1997; 14:321–324.
8. Muzaffar F, Hussain I, Rani Z. Emollients as an adjunct therapy to topical corticosteroids in children with mild to moderate atopic dermatitis. J Pak Assoc Dermatol 2002; 12: 64-8.
Review
For citations:
Kachuk M.V., Muzychenkа A.P., Sikorskaya Т.А. The use of systemic medications in pediatric dermatoses. Military Medicine. 2020;(4):150-153. (In Russ.)
JATS XML